These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 2992657)
81. Genetic (major histocompatibility complex?) control of the antibody repertoire to the secreted antigens of Ascaris. Kennedy MW; Gordon AM; Tomlinson LA; Qureshi F Parasite Immunol; 1987 Mar; 9(2):269-73. PubMed ID: 3574978 [No Abstract] [Full Text] [Related]
82. Ascaris lumbricoides: monoclonal antibodies against the major cuticular collagen. Martin LH; Pasternak JJ Exp Parasitol; 1986 Jun; 61(3):281-3. PubMed ID: 2423361 [No Abstract] [Full Text] [Related]
83. Hepatic and renal clearance of sodium cromoglycate. Clark B; Neale MG J Pharm Pharmacol; 1981 Nov; 33(11):744-5. PubMed ID: 6118421 [No Abstract] [Full Text] [Related]
84. The Effect of Cromolyn Sodium and Nedocromil Sodium Administered by A pressurized Aerosol with A spacer Device on Exercise-Induced Asthma in Children. de Benedictis FM; Tuteri G; Niccoli A; Mezzetti D; Rossi L; Bruni L Mediators Inflamm; 1994; 3(7):S35-7. PubMed ID: 18475602 [TBL] [Abstract][Full Text] [Related]
85. Early use of inhaled nedocromil sodium in children following an acute episode of asthma. Edwards AM; Lyons J; Weinberg E; Weinberg F; Gillies JD; Reid G; Robertson CF; Robinson P; Dalton M; Van Asperen P; Wilson C; Mullineux J; Mullineux A; Sly PD; Cox M; Isles AF Thorax; 1999 Apr; 54(4):308-15. PubMed ID: 10092691 [TBL] [Abstract][Full Text] [Related]
86. Nedocromil sodium. An updated review of its pharmacological properties and therapeutic efficacy in asthma. Brogden RN; Sorkin EM Drugs; 1993 May; 45(5):693-715. PubMed ID: 7686465 [TBL] [Abstract][Full Text] [Related]
88. Respiratory and allergic disease. I. Chung KF; Barnes PJ Br Med J (Clin Res Ed); 1988 Jan; 296(6614):29-33. PubMed ID: 2892563 [No Abstract] [Full Text] [Related]
89. The effect of nedocromil on weal reactions in human skin. Humphreys F; Shuster S Br J Clin Pharmacol; 1987 Oct; 24(4):405-8. PubMed ID: 2891367 [TBL] [Abstract][Full Text] [Related]
90. The effect of nedocromil sodium, sodium cromoglycate and codeine phosphate on citric acid-induced cough in dogs. Jackson DM Br J Pharmacol; 1988 Mar; 93(3):609-12. PubMed ID: 2836011 [TBL] [Abstract][Full Text] [Related]
91. Nedocromil sodium. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of reversible obstructive airways disease. Gonzalez JP; Brogden RN Drugs; 1987 Nov; 34(5):560-77. PubMed ID: 2826101 [TBL] [Abstract][Full Text] [Related]
92. The pharmacokinetics of nedocromil sodium, a new drug for the treatment of reversible obstructive airways disease, in human volunteers and patients with reversible obstructive airways disease. Neale MG; Brown K; Foulds RA; Lal S; Morris DA; Thomas D Br J Clin Pharmacol; 1987 Oct; 24(4):493-501. PubMed ID: 2825746 [TBL] [Abstract][Full Text] [Related]
96. Effects of sodium cromoglycate and nedocromil sodium on histamine secretion from human lung mast cells. Leung KB; Flint KC; Brostoff J; Hudspith BN; Johnson NM; Lau HY; Liu WL; Pearce FL Thorax; 1988 Oct; 43(10):756-61. PubMed ID: 2462755 [TBL] [Abstract][Full Text] [Related]
97. The effects of nedocromil sodium on the response to grain dust in West Australian grain workers. Blainey AD; Musk AW; Ryan G; Phillips MJ; Buccilli C; Troon S; Kidd G Br J Ind Med; 1990 Oct; 47(10):692-7. PubMed ID: 2171630 [TBL] [Abstract][Full Text] [Related]